PetVivo Holdings, Inc. (PETV) Q4 2026 Earnings Call Prepared Remarks Transcript
PetVivo Holdings, Inc. (PETV) Discusses Spryng Technology Adoption and Commercial Expansion in Veterinary Practice Transcript
PetVivo Holdings, Inc. (PETV) Q3 2026 Earnings Call Transcript
| Health Care Equipment & Supplies Industry | Healthcare Sector | John Lai CEO | NASDAQ (CM) Exchange | 716817408 CUSIP |
| US Country | 20 Employees | - Last Dividend | 30 Dec 2020 Last Split | 23 May 2013 IPO Date |
PetVivo Holdings, Inc. stands out as a dynamic biomedical device company dedicated to the design, manufacture, and marketing of medical devices and biomaterials aimed at treating conditions and diseases affecting animals. Founded in the year 2009 and with its headquarters situated in Minneapolis, Minnesota, the company has carved a niche for itself in the veterinary industry by focusing on the development and commercialization of innovative solutions for pets and livestock. Its activities span from the licensing of its groundbreaking technologies to the full-scale commercial production of its proprietary veterinary devices. Through its efforts, PetVivo aims to improve the quality of life for animals suffering from various afflictions, leveraging its expertise in the biomedical field to bring about positive changes in veterinary medicine.
PetVivo Holdings, Inc. has made significant strides in the veterinary medicine field with the introduction of various products, particularly focusing on the management of joint health and the enhancement of animal mobility. Key offerings include: